Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endometrioma Cystic Fluid Aspiration and Retained Ethanol Sclerotherapy Might Improve the Systemic Immune Milieu

NCT05470972 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT05470972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05470972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endometrioma Cystic Fluid Aspiration and Retained Ethanol Sclerotherapy Might Improve the Systemic Immune Milieu
Lead sponsor
Tanta University
Phase
Phase 1
Overall status
Completed
Start date
May 21, 2020
Completion date
May 19, 2022
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis